Article Details
Retrieved on: 2025-02-18 21:54:00
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Johnson & Johnson's challenges in the U.S. capital markets with their Varipulse PFA device. Analysts like RBC Capital Markets and J.P. Morgan provide insights on competition and safety concerns affecting its rollout against rivals like Boston Scientific.
Article found on: www.medtechdive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here